CSA - Pfizer 212511 B5201002 Phase 3 Randomized Multicenter Trial

Clinical Trial Grant

Duke Scholars

Co-Principal Investigator Jennifer Ann Rothman Pediatrics, Hematology-Oncology

Principal Investigator Marilyn Jo Telen Medicine, Hematology

Administered By

Medicine, Hematology

Awarded By

Pfizer, Inc.

Start Date

December 1, 2015

End Date

August 20, 2021

Administered By

Medicine, Hematology

Awarded By

Pfizer, Inc.

Start Date

December 1, 2015

End Date

August 20, 2021